Earnings Feed
Start Free
Home/Insiders/Endicott David J.
ED
SEC Insider//CIK 0001532133

Endicott David J.

CIK 00015321334 companiesIRVINE, CA
SEC Profile

Transactions

35

Companies

4

Filings

13

CIK

0001532133

Recent Transactions

35 trades
  • Award
    Orexigen Therapeutics, Inc.

    Stock Option (Right to Buy)

    2017-07-14+5,000→ 5,000 total
  • Other
    Zeltiq Aesthetics Inc

    Common Stock

    2017-04-28−16,132→ 0 total
  • Award
    Orexigen Therapeutics, Inc.

    Stock Option

    2016-07-12+15,000→ 15,000 total
  • Award
    Zeltiq Aesthetics Inc

    Common Stock

    2016-06-16$28.23/sh+6,199→ 16,132 total
  • Award
    Zeltiq Aesthetics Inc

    Common Stock

    2016-04-25+9,933→ 9,933 total
  • Exercise/Conversion
    HOSPIRA INC

    Stock Options (right to buy)

    2015-09-03−72,971→ 0 total
  • Disposition to Issuer
    HOSPIRA INC

    Common Stock

    2015-09-03$90.00/sh−205,668→ 0 total
  • Award
    HOSPIRA INC

    Common Stock

    2015-09-03+15,196→ 132,697 total
  • Exercise/Conversion
    HOSPIRA INC

    Common Stock

    2015-09-03$43.01/sh+72,971→ 205,668 total
  • Award
    Orexigen Therapeutics, Inc.

    Stock Option (right to buy)

    2015-06-09+50,000→ 50,000 total
  • Award
    HOSPIRA INC

    Common Stock

    2015-02-25$87.50/sh+40,000→ 117,501 total
  • Award
    Orexigen Therapeutics, Inc.

    Stock Option (right to buy)

    2013-06-05+18,126→ 18,126 total
  • Award
    Orexigen Therapeutics, Inc.

    Stock Option (right to buy)

    2013-06-05+35,000→ 35,000 total
  • Award
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2013-02-21+40,000→ 40,000 total
  • Tax Payment
    ALLERGAN INC

    Common Stock

    2013-02-20$108.08/sh−2,794→ 17,335 total
  • Tax Payment
    ALLERGAN INC

    Common Stock

    2013-02-15$108.02/sh−225→ 20,129 total
  • Sale
    ALLERGAN INC

    Common Stock

    2012-11-29$92.27/sh−100→ 22,192 total
  • Exercise/Conversion
    ALLERGAN INC

    Common Stock

    2012-11-29$64.47/sh+100→ 20,452 total
  • Exercise/Conversion
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-11-29−100→ 1,840 total
  • Exercise/Conversion
    ALLERGAN INC

    Common Stock

    2012-11-29$64.47/sh+1,840→ 22,292 total
  • Sale
    ALLERGAN INC

    Common Stock

    2012-11-29$92.33/sh−1,840→ 20,352 total
  • Exercise/Conversion
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-11-29−1,840→ 0 total
  • Award
    Orexigen Therapeutics, Inc.

    Stock Option (right to buy)

    2012-11-29−35,000→ 35,000 total
  • Exercise/Conversion
    ALLERGAN INC

    Common Stock

    2012-11-29$64.47/sh+52,560→ 72,912 total
  • Exercise/Conversion
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-11-29−52,560→ 1,940 total
  • Sale
    ALLERGAN INC

    Common Stock

    2012-11-29$92.43/sh−52,560→ 20,352 total
  • Exercise/Conversion
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-05-07−15,000→ 15,000 total
  • Exercise/Conversion
    ALLERGAN INC

    Common Stock

    2012-05-07$40.16/sh+15,000→ 35,352 total
  • Exercise/Conversion
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-05-07−12,500→ 25,000 total
  • Exercise/Conversion
    ALLERGAN INC

    Common Stock

    2012-05-07$59.13/sh+12,500→ 47,852 total
  • Sale
    ALLERGAN INC

    Common Stock

    2012-05-07$93.81/sh−27,500→ 20,352 total
  • Tax Payment
    ALLERGAN INC

    Common Stock

    2012-02-22$87.27/sh−212→ 20,352 total
  • Award
    ALLERGAN INC

    Common Stock

    2012-02-17+378→ 20,564 total
  • Award
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-02-17+15,000→ 15,000 total
  • Award
    ALLERGAN INC

    Employee Stock Option (Right to Buy)

    2012-02-17+38,000→ 38,000 total

Companies

4

Recent Filings

13

Address

2525 DUPONT DRIVE

IRVINE, CA, 92612

View on SEC.gov